Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the Answer of 20 June 2022 to Question 19015 on Medical Treatments: Innovation, if his Department will take steps to help ensure that research and data collected by the (a) Innovative Medicines Fund and (b) Cancer Drugs Fund will be shared with NHS bodies in the devolved legislatures.

There are existing mechanisms in place where the outcomes of the Cancer Drugs Fund (CDF) and the Innovative Medicines Fund (IMF) are available to the devolved administrations. Medicines funded through the CDF and subsequently from the IMF are re-appraised by the National Institute for Health and Care Excellence (NICE) to determine whether the products can be routinely funded by the National Health Service, including with evidence generated through the CDF and IMF. NICE publishes the papers considered by its appraisal committees online, including the outcomes from data collected through the CDF and IMF on outstanding clinical uncertainties.